Table 4.
Analytical characteristics of FPSE-GC-MS method for NSAIDs.
| Drug | LOD (µg mL−1) |
LOQ (µg mL−1) |
R2 | Linearity (µg mL−1) |
Calibration Curve | Precision (%RSD) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Intra-Day (µg mL−1) |
Inter-Day (µg mL−1) |
||||||||||
| 0.3 | 1 | 10 | 0.3 | 1 | 10 | ||||||
| DIC | 0.0049 | 0.016 | 0.998 | 0.1–10 | y = (17,062 ± 297.6)x + (29,015 ± 1365.9) | 5.2 | 4.1 | 3.1 | 6.2 | 8.1 | 9.2 |
| IBU | 0.0022 | 0.0072 | 0.999 | 0.1–10 | y = (35,576 ± 447.8)x + (22,877 ± 2055.1) | 3.8 | 6.2 | 5.8 | 8.0 | 5.4 | 6.5 |
| NAP | 0.0015 | 0.0049 | 0.999 | 0.1–10 | y = (43,090± 429.5)x + (41,269 ± 1971.3) | 4.6 | 3.7 | 2.4 | 9.5 | 7.1 | 5.6 |
| KET | 0.0031 | 0.0103 | 0.999 | 0.1–10 | y = (13,066 ± 128.6)x + (28,573 ± 590.3) | 6.2 | 4.9 | 3.5 | 7.5 | 6.4 | 8.8 |